RTOG-0618

Terminated

Return to Protocol Table

A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer

Principal Investigator

Robert D. Timmerman

Status

Terminated

Closed to Accrual & Treatment

May 20, 2010

Complete

March 6, 2018

Terminated

May 14, 2018


Disease Site

Lung [LU] Non-small Cell Lung Cancer

Phase

II

Developmental Therapeutics

No

Primary Objective

The primary objective of the study is to determine whether radiotherapy involving high biological dose with limited treatment volume (using SBRT techniques) achieves acceptable primary tumor control (i.e., = >90% at 2 years) in operable patients with early-stage NSCLC.

Data Collection Notice:

Data for this trial is being collected via the NRG/RTOG Data Center.

Patient Population

 

Patients with T1, T2 (<= 5 cm), T3 (<= 5 cm), N0, M0 operable non-small cell lung cancer; patients with T3 tumors must have chest wall primary tumors only; no patients with tumors of any T-stage in the zone of the proximal bronchial tree. Patients with T3 tumors based on mediastinal invasion or < 2 cm toward carina invasion are not eligible.

Target Accrual

33

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.